Font Size:
a
A
A
Keyword [Relapsed/Refractory]
Result: 61 - 68 | Page: 4 of 4
61.
Efficacy And Safety Of Venetoclax-based Combinational Therapies In The Treatment Of Relapsed/Refractory Acute Myeloid Leukemia:a Meta-analysis
62.
Retrospective Study Of Bortezomib,Pomalidomide And Dexamethasone(VPd) Regimen In The Treatment Of Relapsed/Refractory Multiple Myeloma
63.
Analysis Of The Efficacy And Safety Of Venetociax Combined With Hypomethylating Agents In Patients With Acute Myeloid Leukemia
64.
Efficacy And Safety Study Of Bridging Allogeneic Haematopoietic Stem Cell Transplantation After CAR-T Cells Therapy For Adult Relapsed/Refractory Acute B Lymphoblastic Leukemia
65.
Clinical Study Of CD19 Prime CAR T Cell For Relapsed/refractory Acute B-lymphocytic Leukemia
66.
Efficacy Of Pomalidomide-containing Regimen For Relapsed Refractory Multiple Myeloma And Analysis Of Factors Influencing The Treatment
67.
To Observe The Efficacy Of Bendamustine Combined With Pomalidomide And Dexamethasone In The Treatment Of Relapsed/Refractory Multiple Myeloma
68.
High-throughput Drug Sensitivity Screening (HDS) Guided Treatment For Children With Refractory Or Relapsed Leukemia
<<First
<Prev
Next>
Last>>
Jump to